157 related articles for article (PubMed ID: 8852444)
21. PHENOTYPIC CHARACTERISTICS OF TROPHOBLASTIC HYPERPLASIA AND MICROENVIRONMENT ALTERATIONS IN CHORIONIC VILLI IN SPONTANEOUS ABORTIONS.
Chikvaidze N; Kintraia N; Muzashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 Jun; (291):117-121. PubMed ID: 31418743
[TBL] [Abstract][Full Text] [Related]
22. The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole.
Saxena A; Frank D; Panichkul P; Van den Veyver IB; Tycko B; Thaker H
Placenta; 2003; 24(8-9):835-42. PubMed ID: 13129680
[TBL] [Abstract][Full Text] [Related]
23. Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease.
Petts G; Fisher RA; Short D; Lindsay I; Seckl MJ; Sebire NJ
J Reprod Med; 2014; 59(5-6):213-20. PubMed ID: 24937960
[TBL] [Abstract][Full Text] [Related]
24. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole.
Cheville JC; Robinson R; Benda JA
Pediatr Pathol Lab Med; 1996; 16(1):41-50. PubMed ID: 8963630
[TBL] [Abstract][Full Text] [Related]
26. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
[TBL] [Abstract][Full Text] [Related]
27. Low molecular mass polypeptide-2 in human trophoblast: over-expression in hydatidiform moles and possible role in trophoblast cell invasion.
Fu JJ; Lin P; Lv XY; Yan XJ; Wang HX; Zhu C; Tsang BK; Yu XG; Wang H
Placenta; 2009 Apr; 30(4):305-12. PubMed ID: 19217658
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions.
Montes M; Roberts D; Berkowitz RS; Genest DR
Am J Clin Pathol; 1996 Apr; 105(4):411-6. PubMed ID: 8604683
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructure of molar trophoblast. Observations on hydatidiform mole and chorioadenoma destruens.
Okudaira Y; Strauss L
Obstet Gynecol; 1967 Aug; 30(2):172-87. PubMed ID: 4378046
[TBL] [Abstract][Full Text] [Related]
31. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
32. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
33. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
34. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
36. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
37. A bioinformatics transcriptome meta-analysis highlights the importance of trophoblast differentiation in the pathology of hydatidiform moles.
Desterke C; Slim R; Candelier JJ
Placenta; 2018 May; 65():29-36. PubMed ID: 29908639
[TBL] [Abstract][Full Text] [Related]
38. Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles.
Murphy KM; Carrick K; Gwin K; Rogers V; Koduru P; Ronnett BM; Castrillon DH
Int J Gynecol Pathol; 2022 Jan; 41(1):45-50. PubMed ID: 33900230
[TBL] [Abstract][Full Text] [Related]
39. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
40. Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis.
Jeffers MD; O'Dwyer P; Curran B; Leader M; Gillan JE
Int J Gynecol Pathol; 1993 Oct; 12(4):315-23. PubMed ID: 8253548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
